Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DHEA + melatonin for sleep and mood in postmenopausal women
2024-520234-30-00Phase 3Authorised
- Sponsor
- Lek-AM
- Start
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in menopause, Insomnia, major depressive disorder (MDD) and 1 more comparing DHEA 20 mg + prolonged-release melatonin 2 mg with Placebo (2 arms). Planned start Jan 2025; status: authorised.
02
Drugs
prasteronemelatonin
03
Conditions
menopauseInsomniamajor depressive disorder (MDD)vasomotor symptoms
Beyond the preview
Go deeper on 2024-520234-30-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-520234-30-00.